Overview: Caisse Régionale de Crédit Agricole Mutuel de Normandie-Seine Société coopérative provides a range of banking products and services to individuals, professionals, farmers, associations, and companies in France with a market cap of €433.60 million.

Operations: The company's revenue streams are derived from providing various banking products and services to a diverse clientele in France. It has a market cap of €433.60 million.

Caisse Régionale de Crédit Agricole Mutuel de Normandie-Seine Société coopérative, with total assets of €25.5B and total equity of €3.0B, reported earnings growth of 4% over the past year, outpacing the -2.7% industry average. The bank has a sufficient allowance for bad loans at 115%, covering its appropriate level of bad loans (1%). Total deposits stand at €7.9B against total loans of €22.0B, reflecting robust financial health despite higher-risk funding sources making up 65% of liabilities.

• Navigate through the intricacies of Caisse Régionale de Crédit Agricole Mutuel de Normandie-Seine Société coopérative with our comprehensive health report here.

• Understand Caisse Régionale de Crédit Agricole Mutuel de Normandie-Seine Société coopérative's track record by examining our Past report.

Neurones

Simply Wall St Value Rating: ★★★★★☆

Overview: Neurones S.A. is an IT services company offering infrastructure, application, and consulting services in France and internationally, with a market cap of €1.04 billion.

Operations: Neurones generates revenue primarily from infrastructure, application, and consulting services. The company has a market cap of €1.04 billion.

Neurones reported half-year revenue of €402.43 million, up from €368.69 million last year, with net income slightly down to €24.5 million from €25.42 million. Basic earnings per share were stable at €1.01 compared to the previous year's €1.05. Over the past year, earnings grew by 1.8%, outpacing the IT industry's -7.4%. The debt-to-equity ratio rose to 2.8% over five years, but Neurones has more cash than total debt and generates high-quality earnings.

• Unlock comprehensive insights into our analysis of Neurones stock in this health report.

• Review our historical performance report to gain insights into Neurones''s past performance.

Where To Now?

• Click through to start exploring the rest of the 28 Euronext Paris Undiscovered Gems With Strong Fundamentals now.

• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.

• Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Ready For A Different Approach?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ENXTPA:AXW ENXTPA:CCN and ENXTPA:NRO.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]